Together, our results demonstrated the contribution of hypoxia to ROS production in MCL, as previously shown in other aggressive tumors29, and suggest that SOX11 might be involved in cell adaptation to hypoxia via increased levels of PRDX2 and ROS in MCL cells. Here, PRDX2 is linked to mantle cell lymphoma.